(NYSE MKT:PMI), NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Picard Medical, Inc. (NYSE American: PMI) between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”), of the important April 13, 2026 lead plaintiff deadline. SO WHAT: If […]
ROSEN, LEADING TRIAL LAWYERS, Encourages Picard Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PMI GlobeNewswire March 07, 2026 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Picard Medical, Inc. (NYSE American: PMI) between
(NASDAQ:SDM), NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Smart Digital Group Ltd. (NASDAQ: SDM) between May 5, 2025 and September 26, 2025 at 9:34 AM EST, both dates inclusive (the “Class Period”), of the important March 16, 2026 lead
SDM DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Smart Digital Group Ltd. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action – SDM GlobeNewswire March 07, 2026 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Smart
(NASDAQ:RARE), NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the “Class Period”), of the important April 6, 2026 lead plaintiff deadline. SO WHAT: If you
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RARE GlobeNewswire March 07, 2026 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)
GDP growth of 4.5 percent to 5 percent, while striving for better results in practice – this is one of the main development targets for this year outlined in the Government Work Report. Economic growth targets have long attracted close attention. Over the past three years, China set its GDP growth target at around 5
Baltimore, MD, March 06, 2026 (GLOBE NEWSWIRE) — Former CIA advisor Jim Rickards has released a new video presentation examining what he believes could become a defining economic theme as the United States approaches its 250th anniversary: the push to rebuild America's industrial and resource base. In the newly released presentation, Rickards explains why natural
Former Pentagon Advisor Jim Rickards Releases New Presentation on America's Race to Rebuild Its Resource Supply The presentation explores why natural resources, energy, and manufacturing are suddenly back at the center of the U.S. economy GlobeNewswire March 07, 2026 Baltimore, MD, March 06, 2026 (GLOBE NEWSWIRE) — Former CIA advisor Jim Rickards has released a
(NASDAQ:SLNO), SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2025, inclusive (the “Class Period”), have until May 5, 2026 to seek appointment as lead plaintiff of the Soleno class action lawsuit.